Technical Analysis for SYRE - Spyre Therapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Pocket Pivot | Bullish Swing Setup | 3.09% | |
Doji - Bearish? | Reversal | 3.09% | |
Upper Bollinger Band Walk | Strength | 3.09% | |
Earnings Movers | Other | 3.09% | |
Overbought Stochastic | Strength | 3.09% | |
Up 3 Days in a Row | Strength | 3.09% | |
Up 4 Days in a Row | Strength | 3.09% | |
Up 5 Days in a Row | Strength | 3.09% | |
Upper Bollinger Band Touch | Strength | 3.09% | |
Stochastic Reached Overbought | Strength | 3.67% |
Alert | Time |
---|---|
Rose Above Previous Day's High | 4 minutes ago |
Outside Day | 4 minutes ago |
Up 3% | 4 minutes ago |
Up 2% | 4 minutes ago |
Up 1% | about 3 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/07/2024
Spyre Therapeutics is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Immunology Autoimmune Disease Antibodies Monoclonal Antibody Antibody Inflammatory Bowel Disease
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Immunology Autoimmune Disease Antibodies Monoclonal Antibody Antibody Inflammatory Bowel Disease
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 47.97 |
52 Week Low | 8.43 |
Average Volume | 488,965 |
200-Day Moving Average | 31.00 |
50-Day Moving Average | 30.53 |
20-Day Moving Average | 33.63 |
10-Day Moving Average | 34.99 |
Average True Range | 1.84 |
RSI (14) | 71.26 |
ADX | 29.07 |
+DI | 33.60 |
-DI | 12.14 |
Chandelier Exit (Long, 3 ATRs) | 33.22 |
Chandelier Exit (Short, 3 ATRs) | 31.79 |
Upper Bollinger Bands | 37.75 |
Lower Bollinger Band | 29.50 |
Percent B (%b) | 0.99 |
BandWidth | 24.52 |
MACD Line | 1.83 |
MACD Signal Line | 1.53 |
MACD Histogram | 0.3081 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 40.41 | ||||
Resistance 3 (R3) | 40.45 | 39.59 | 39.95 | ||
Resistance 2 (R2) | 39.59 | 38.90 | 39.57 | 39.80 | |
Resistance 1 (R1) | 38.64 | 38.47 | 39.11 | 38.60 | 39.65 |
Pivot Point | 37.78 | 37.78 | 38.01 | 37.76 | 37.78 |
Support 1 (S1) | 36.83 | 37.09 | 37.30 | 36.79 | 35.73 |
Support 2 (S2) | 35.97 | 36.66 | 35.95 | 35.58 | |
Support 3 (S3) | 35.02 | 35.97 | 35.43 | ||
Support 4 (S4) | 34.98 |